These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33628415)

  • 1. Focus on Depression in Parkinson's Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics.
    Agüera-Ortiz L; García-Ramos R; Grandas Pérez FJ; López-Álvarez J; Montes Rodríguez JM; Olazarán Rodríguez FJ; Olivera Pueyo J; Pelegrín Valero C; Porta-Etessam J
    Parkinsons Dis; 2021; 2021():6621991. PubMed ID: 33628415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management.
    Agüera-Ortiz L; García-Ramos R; Grandas Pérez FJ; López-Álvarez J; Montes Rodríguez JM; Olazarán Rodríguez FJ; Olivera Pueyo J; Pelegrin Valero C; Porta-Etessam J
    Front Psychiatry; 2021; 12():638651. PubMed ID: 33716830
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A; de Filippis R; Proietti L
    World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid.
    Peña E; Mata M; López-Manzanares L; Kurtis M; Eimil M; Martínez-Castrillo JC; Navas I; Posada IJ; Prieto C; Ruíz-Huete C; Vela L; Venegas B;
    Neurologia (Engl Ed); 2016 Mar; ():. PubMed ID: 27004670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and Parkinson's disease.
    Lemke MR; Fuchs G; Gemende I; Herting B; Oehlwein C; Reichmann H; Rieke J; Volkmann J
    J Neurol; 2004 Sep; 251 Suppl 6():VI/24-7. PubMed ID: 15675721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.
    Gallagher DA; Schrag A
    CNS Drugs; 2008; 22(7):563-86. PubMed ID: 18547126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
    Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease.
    Gencler OS; Oztekin N; Oztekin MF
    Ideggyogy Sz; 2022 Jan; 75(1-02):39-49. PubMed ID: 35112520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in Parkinson's disease: diagnosis and treatment.
    Costa FH; Rosso AL; Maultasch H; Nicaretta DH; Vincent MB
    Arq Neuropsiquiatr; 2012 Aug; 70(8):617-20. PubMed ID: 22899034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment of depression in Parkinson's disease.
    Maruyama T
    Int J Psychiatry Clin Pract; 2003; 7 Suppl 1():25-7. PubMed ID: 24937417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management.
    Stocchi F; Angelo Antonini ; Barone P; Bellelli G; Fagiolini A; Ferini Strambi L; Sorbi S; Padovani A
    Neurol Sci; 2023 Sep; 44(9):3123-3131. PubMed ID: 37100925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review.
    Angelopoulou E; Stanitsa E; Karpodini CC; Bougea A; Kontaxopoulou D; Fragkiadaki S; Koros C; Georgakopoulou VE; Fotakopoulos G; Koutedakis Y; Piperi C; Papageorgiou SG
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in Parkinson's Disease: A Narrative Review.
    Chikatimalla R; Dasaradhan T; Koneti J; Cherukuri SP; Kalluru R; Gadde S
    Cureus; 2022 Aug; 14(8):e27750. PubMed ID: 36106206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms in Parkinson's disease.
    Lemke MR
    Eur J Neurol; 2008 Apr; 15 Suppl 1():21-5. PubMed ID: 18353133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.